NEW ENGLAND SECURITIES CORP /MA/ - ONCOGENEX PHARMACEUTICALS IN ownership

ONCOGENEX PHARMACEUTICALS IN's ticker is OGXI and the CUSIP is 68230A106. A total of 76 filers reported holding ONCOGENEX PHARMACEUTICALS IN in Q1 2014. The put-call ratio across all filers is 1.52 and the average weighting 0.1%.

Quarter-by-quarter ownership
NEW ENGLAND SECURITIES CORP /MA/ ownership history of ONCOGENEX PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2014$0540.00%
Other shareholders
ONCOGENEX PHARMACEUTICALS IN shareholders Q1 2014
NameSharesValueWeighting ↓
Steamboat Capital Partners, LLC 817,521$414,0000.37%
Abingworth LLP 396,104$195,0000.19%
BOOTHBAY FUND MANAGEMENT, LLC 60,638$31,0000.01%
EAGLE GLOBAL ADVISORS LLC 128,520$65,0000.00%
PANAGORA ASSET MANAGEMENT INC 949,438$481,0000.00%
Renaissance Technologies 908,100$460,0000.00%
PRICE T ROWE ASSOCIATES INC /MD/ 46,100$23,0000.00%
DEUTSCHE BANK AG\ 5$00.00%
CITIGROUP INC 10,376$5,0000.00%
GOLDMAN SACHS GROUP INC 20,037$10,0000.00%
View complete list of ONCOGENEX PHARMACEUTICALS IN shareholders